Literature DB >> 12150475

Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.

B Mangura1, E Napolitano, M Passannante, M Sarrel, R McDonald, K Galanowsky, L Reichman.   

Abstract

SETTING: New Jersey Medical School National Tuberculosis Center-Lattimore Clinic, a TB Clinic for an inner city population of Newark, New Jersey, USA.
OBJECTIVE: Directly observed therapy (DOT) is the recommended standard of TB care. Recent reports suggest that DOT may not be any better than self-administered therapy (SAT). To quantify the impact of different levels of SAT, DOT, and active case management on outcomes of TB treatment at our location, we reviewed the outcomes of six TB patient-cohorts from Newark between 1 January 1994 and 31 December 1996. STUDY
DESIGN: A retrospective cohort study of the outcomes of 343 tuberculosis patients treated during the years 1994-1996. The three treatment strategies were 1) self-administered with occasional selective directly observed therapy, 2) universal directly observed therapy alone (universal DOT), and 3) universal DOT with nurse case management (NCM).
RESULTS: The first two cohorts who began treatment during the transition may have received more than one treatment strategy. However, universal DOT did not significantly improve the TB treatment completion rates of Cohort 2 over SAT therapy with selective DOT given to Cohort 1. Universal DOT with NCM, Cohorts 3, 4, 5, and 6, significantly increased the TB treatment completion rates by three to six times. A cohort-specific step-wise reduction in duration of treatment from a median of 11.6-7.5 months and an increase in completion rates from 57-81% resulted. The most desirable and optimal (shortest) duration of treatment completion coincided with the application of universal DOT combined with NCM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150475

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

1.  Effect of a hospital-based case management approach on treatment outcome of patients with tuberculosis.

Authors:  Rong-Luh Lin; Fung-J Lin; Chien-Liang Wu; Ming-Jen Peng; Pei-Jan Chen; Hsu-Tah Kuo
Journal:  J Formos Med Assoc       Date:  2006-08       Impact factor: 3.282

2.  Cost and cost-effectiveness of smear-positive tuberculosis treatment by Health Extension Workers in Southern Ethiopia: a community randomized trial.

Authors:  Daniel G Datiko; Bernt Lindtjørn
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

3.  Infection of the Invisible: Impressions of a Tuberculosis Intervention Program for Migrants in Istanbul.

Authors:  Yesim Yasin; Kristen Biehl; Maral Erol
Journal:  J Immigr Minor Health       Date:  2015-10

4.  Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China.

Authors:  Hua Jianzhao; Susan van den Hof; Xu Lin; Qiu Yubang; Hou Jinglong; Marieke J van der Werf
Journal:  BMC Health Serv Res       Date:  2011-05-11       Impact factor: 2.655

5.  Treatment completion among TB patients returned to the community from a large urban jail.

Authors:  Seijeoung Kim; Kathleen Crittenden
Journal:  J Community Health       Date:  2007-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.